Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2373| Título : | Effects of fructans from Mexican agave in newborns fed with infant formula: A randomized controlled trial |
| Creador: | López Velázquez, Gabriel |
| Nivel de acceso: | Open access |
| Palabras clave : | Agave - química Huesos - efectos de drogas Huesos - metabolismo Proteína C-Reactiva - metabolismo Femenino Ferritins - sangre Fructanos - farmacología Microbioma Gastrointestinal -efectos de drogas Estado de Salud Humanos Inmunidad - Efectos de drogas Fórmulas Infantiles - química Recién nacido Masculino México Proyectos Piloto Extractos Vegetales - farmacología Prebióticos Valores de Referencia Resultado del Tratamiento Agave - chemistry Bone and Bones - drug effects Bone and Bones - metabolism C-Reactive Protein - metabolism Female Ferritins - blood Fructans - pharmacology Gastrointestinal Microbiome - drug effects Health Status Humans Immunity - drug effects Infant Formula - chemistry Infant, Newborn Male Mexico Pilot Projects Plant Extracts - pharmacology Prebiotics Reference Values Treatment Outcome Leche materna Respuesta inmunitaria Microbiota infantil fibra soluble breast milk immune response infant microbiota soluble fiber |
| Descripción : | BACKGROUND: The importance of prebiotics consumption is increasing all over the world due to their beneficial effects on health. Production of better prebiotics from endemic plants raises possibilities to enhance nutritional effects in vulnerable population groups. Fructans derived from Agave Plant have demonstrated their safety and efficacy as prebiotics in animal models. Recently, the safety in humans of two fructans obtained from Agave tequilana (Metlin(®) and Metlos(®)) was demonstrated. METHODS: This study aimed to demonstrate the efficacy as prebiotics of Metlin(®) and Metlos(®) in newborns of a randomized, double blind, controlled trial with a pilot study design. Biological samples were taken at 20 ± 7 days, and three months of age from healthy babies. Outcomes of efficacy include impact on immune response, serum ferritin, C-reactive protein, bone metabolism, and gut bacteria changes. RESULTS: There were differences statistically significant for the groups of infants fed only with infant formula and with formula enriched with Metlin(®) and Metlos(®). CONCLUSIONS: Our results support the efficacy of Metlin(®) and Metlos(®) as prebiotics in humans, and stand the bases to recommend their consumption. TRIAL REGISTRATION: ClinicalTrials.gov, NCT 01251783. |
| Colaborador(es) u otros Autores: | Parra-Ortiz M Mora Ide L García-Torres I Enríquez-Flores S Alcántara-Ortigoza MA Angel AG Velázquez-Aragón Ortiz-Hernández R Cruz-Rubio JM Villa-Barragán P Jiménez-Gutiérrez C Gutiérrez-Castrellón P |
| Fecha de publicación : | 2015 |
| Tipo de publicación: | Artículo |
| Formato: | |
| Identificador del Recurso : | 10.3390/nu7115442 |
| Fuente: | Nutrients 7(11):8939 - 8951 |
| URI : | http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2373 |
| Idioma: | eng |
| Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.